Urachal carcinoma: towards a precision medicine

被引：7
作者：
Mennitto, Alessia [1 ]
Vernieri, Claudio [1 ]
Procopio, Giuseppe [1 ]
机构：
[1] Ist Nazl Tumori, Fdn IRCCS, Dept Med Oncol, Milan, Italy
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; COMBINATION; ERLOTINIB; ADENOCARCINOMA; CHEMOTHERAPY; METAANALYSIS; GEMCITABINE; CARBOPLATIN;
D O I：
10.21037/tcr.2016.12.28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1307 / S1310
页数：4
相关论文
共 23 条
[1]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[2]   Urachal carcinoma: Clinicopathologic features and long-term outcomes of an aggressive malignancy [J].
Ashley, Richard A. ;
Inman, Brant A. ;
Sebo, Thomas J. ;
Leibovich, Bradley C. ;
Blute, Michael L. ;
Kwon, Eugene D. ;
Zincke, Horst .
CANCER, 2006, 107 (04) :712-720
[3]   The Clinical Epidemiology of Urachal Carcinoma: Results of a Large, Population Based Study [J].
Bruins, H. Max ;
Visser, Otto ;
Ploeg, Martine ;
Hulsbergen-van de Kaa, Christina A. ;
Kiemeney, Lambertus A. L. M. ;
Witjes, J. Alfred .
JOURNAL OF UROLOGY, 2012, 188 (04) :1102-1107
[4]   Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer [J].
Corcoran, Ryan B. ;
Atreya, Chloe E. ;
Falchook, Gerald S. ;
Kwak, Eunice L. ;
Ryan, David P. ;
Bendell, Johanna C. ;
Hamid, Omid ;
Messersmith, Wells A. ;
Daud, Adil ;
Kurzrock, Razelle ;
Pierobon, Mariaelena ;
Sun, Peng ;
Cunningham, Elizabeth ;
Little, Shonda ;
Orford, Keith ;
Motwani, Monica ;
Bai, Yuchen ;
Patel, Kiran ;
Venook, Alan P. ;
Kopetz, Scott .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) :4023-+
[5]   Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer [J].
Di Nicolantonio, Federica ;
Martini, Miriam ;
Molinari, Francesca ;
Sartore-Bianchi, Andrea ;
Arena, Sabrina ;
Saletti, Piercarlo ;
De Dosso, Sara ;
Mazzucchelli, Luca ;
Frattini, Milo ;
Siena, Salvatore ;
Bardelli, Alberto .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5705-5712
[6]   Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial [J].
Gatzemeier, Ulrich ;
Pluzanska, Anna ;
Szczesna, Aleksandra ;
Kaukel, Eckhard ;
Roubec, Jaromir ;
De Rosa, Flavio ;
Milanowski, Janusz ;
Karnicka-Mlodkowski, Hanna ;
Pesek, Milos ;
Serwatowski, Piotr ;
Ramlau, Rodryg ;
Janaskova, Terezie ;
Vansteenkiste, Johan ;
Strausz, Janos ;
Manikhas, Georgy Moiseevich ;
Von Pawel, Joachim .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1545-1552
[7]   Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1 [J].
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Scagliotti, G ;
Rosell, R ;
Miller, V ;
Natale, RB ;
Schiller, JH ;
von Pawel, J ;
Pluzanska, A ;
Gatzemeier, M ;
Grous, J ;
Ochs, JS ;
Averbuch, SD ;
Wolf, MK ;
Rennie, P ;
Fandi, A ;
Johnson, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :777-784
[8]   A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group [J].
Goss, G ;
Hirte, H ;
Miller, WH ;
Lorimer, IAJ ;
Stewart, D ;
Batist, G ;
Parolin, DAE ;
Hanna, P ;
Stafford, S ;
Friedmann, J ;
Walsh, W ;
Mathews, S ;
Douglas, L ;
Seymour, LK .
INVESTIGATIONAL NEW DRUGS, 2005, 23 (02) :147-155
[9]   The predictive value of epidermal growth factor receptor tests in patients with pulmonary adenocarcinoma: review of current "best evidence" with meta-analysis [J].
Gupta, Ruta ;
Dastane, Aditi M. ;
McKenna, Robert, Jr. ;
Marchevsky, Atberto M. .
HUMAN PATHOLOGY, 2009, 40 (03) :356-365
[10]   Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2 [J].
Herbst, RS ;
Giaccone, G ;
Schiller, JH ;
Natale, RB ;
Miller, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :785-794
123